AkaRx


Public lists: Pharma Startups (4732)

AkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.

AkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.

Company (Alive / Active)

All investors data 3 Investors

Phone: 201-909-3000

Fax: 201-909-3004

Mack Centre IV
4th Floor
 Paramus, 07652
 New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AkaRx $12.5M May 17, 2016
PlantForm Corporation $0M Nov 29, 2018
INDENA SPA $0M Nov 29, 2018
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AkaRx Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

Name Firm
Login to see detailsInterWest Partners

Competitors

Company Status Description Investors
See all 17 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)